About Tissuetech, inc
Tissuetech, Inc. is a leading biotechnology company that specializes in providing innovative adjunct therapies through a comprehensive line of ocular surface products. The company's flagship products include Prokera®, AmnioGraft®, and AmnioGuard®.
Prokera® is a unique therapeutic device that helps to heal and protect the ocular surface. It is made up of cryopreserved amniotic membrane tissue, which contains natural growth factors and anti-inflammatory agents that promote healing and reduce scarring. Prokera® has been clinically proven to be effective in treating various eye conditions such as dry eye syndrome, corneal abrasions, chemical burns, and more.
AmnioGraft® is another innovative product from Tissuetech that uses amniotic membrane tissue to promote healing in chronic wounds. This product has been shown to be effective in treating diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types of chronic wounds.
AmnioGuard® is a sterile solution made from amniotic fluid that contains growth factors and anti-inflammatory agents. This product can be used as an adjunct therapy for various surgical procedures such as cataract surgery or corneal transplants to help reduce inflammation and promote healing.
Tissuetech's products are backed by extensive research and clinical trials conducted by leading ophthalmologists around the world. The company's commitment to innovation has led to the development of cutting-edge technologies that have revolutionized the field of ocular surface therapy.
In addition to its line of ocular surface products, Tissuetech also offers training programs for healthcare professionals on how to use its products effectively. The company's team of experts provides ongoing support for healthcare providers who use its products in their practice.
Tissuetech's mission is simple: To improve patient outcomes by providing innovative solutions for ocular surface disorders and chronic wound care. With its commitment to excellence in research, development, manufacturing, education, training & support services; Tissuetech continues striving towards achieving this goal every day!
In conclusion,Tissuetech Inc.'s innovative approach towards developing cutting-edge technologies has revolutionized the field of ocular surface therapy.Their comprehensive line-up includes Prokera®, AmnioGraft®, & AmnioGuard®, which have been clinically proven effective against various eye conditions & chronic wounds.TissueTech’s commitment towards excellence makes them one-of-a-kind biotech companies out there!